Ironwood Pharmaceuticals Inc specializes in creating gastrointestinal (GI) treatments, offering relief for conditions like irritable bowel syndrome and chronic constipation through its flagship product, LINZESS. Beyond its core offerings, the company is exploring new therapies for visceral pain and rare diseases, including short bowel syndrome and primary biliary cholangitis. With strategic partnerships enhancing its reach, Ironwood stands out in the healthcare sector for its innovative approach to GI disorders and commitment to improving patient quality of life.